Revvity IR

Official Account of @Revvityinc Investor Relations $RVTY

[Revvity IR @RevvityIR]

$RVTY

[Barron's @barronsonline]

From Nvidia to Mercedes: 48 Picks for the Rest of the Year, From Barron’s Roundtable Pros https://t.co/8xAoewt9aE

[Revvity IR @RevvityIR]

Excited that $RVTY is a part of this groundbreaking research study by @RTI_Intl which is utilizing our recently introduced next-gen sequencing workflows for newborn screening @RevvityInc @RevvityDX
https://t.co/gWvmdc27hp

[Revvity IR @RevvityIR]

$RVTY

[Revvity @RevvityInc]

We are proud to participate in the @NYSE Global Giving Campaign to highlight our partnership with the @LLSusa. Our ornament can be seen at NYSE for their 100th Tree Lighting on Nov. 30 and through the holiday season. #NYSETreeLighting https://t.co/XrzRoQRzBo

[Revvity IR @RevvityIR]

Today, Revvity launched our 2023 annual ESG report.
I hope you’ll take a few minutes to read it and learn about the positive impact we’re making on society beyond just our significant contributions to advancing science and the diagnosis of disease. $RVTY
https://t.co/WoiL6Ijyow

[Revvity IR @RevvityIR]

Excited for today's launch of our first "Pin-point" base editing reagents. Scientists now have off the shelf consumables to explore the possibilities of multi-gene editing using a novel base editing technology. #baseediting $RVTY
https://t.co/gR59PLMSzA

[Revvity IR @RevvityIR]

It was great to participate in the @GoldmanSachs healthcare investor conference today. We covered a large variety of topics during our CFO's fireside chat which you can listen to a replay of here: https://t.co/YF7uEZPgTt
$RVTY

[Revvity IR @RevvityIR]

$RVTY

[Revvity @RevvityInc]

.@GENbio caught up with experts in base and prime editing, which has potential in a variety of therapeutic applications. Our Pin-point base editing system is capable of making transition point mutations with high precision and efficiency. Read here: https://t.co/0aW9sI6MYM

[Revvity IR @RevvityIR]

$RVTY

[Revvity for Life Sciences @RevvityLifeSci]

In our pursuit to bridge the gap between science & people, we are excited to announce a new license agreement w/ AstraZeneca for the technology underlying our Pin-point™ Base Editing Platform, a novel, next-gen modular base editing system.

Learn more: https://t.co/F9QTRLlT4G

[Revvity IR @RevvityIR]

$RVTY and on the 101 in Silicon Valley

[Revvity @RevvityInc]

We proudly introduced #Revvity in #TimesSquare! Our monumental billboard represents the power of passionate minds uniting. #WeAreRevvity

[Revvity IR @RevvityIR]

Nice article from @endpts this morning on our Pin-Point base editing licensing announcement $RVTY
https://t.co/Xg5w5iAs9b

Press release here: https://t.co/ZWNEckrdG4

Learn more here: https://t.co/tDSTbC8hBs

[Revvity IR @RevvityIR]

This video provides a glimpse into the fantastic day we had yesterday @NYSE. Take a look..... $RVTY

[Revvity @RevvityInc]

Yesterday was a historic day for #Revvity. We're thrilled to have joined the @NYSE and to have had the opportunity to ring the bell.

[Revvity IR @RevvityIR]

Today was an exciting day for @RevvityInc. Thank you @NYSE for helping us celebrate our new brand launch and ticker change $RVTY

[NYSE 🏛 @NYSE]

The NYSE welcomes @RevvityInc as it celebrates its formal launch as a new scientific solutions company seeking to solve the world’s greatest health challenges. $RVTY

[Revvity IR @RevvityIR]

Tomorrow is an exciting day, the @RevvityInc team will be at the @NYSE to ring the opening bell to celebrate our recent brand launch & the first day of trading under our new ticker $RVTY ...... watch along here:
https://t.co/Xgod5hMIkZ
https://t.co/3CIv8fQw2x;

[Revvity IR @RevvityIR]

Learn more about #Revvity and how we help our customers push the boundaries of human potential through science. Check out https://t.co/8wVgFJltQx and https://t.co/4uXxBSYmmQ to learn more $RVTY

[Revvity IR @RevvityIR]

Have been having an awesome time at our @Revvityinc kick off meeting this week in Dallas with ~1,500 of my colleagues. Am excited to #embracetheimpossible together going forward! $RVTY #Wearerevvity

[Revvity IR @RevvityIR]

We’re excited to share some big news! Today, $PKI announced that it has finalized the divesture of its Analytical & Enterprise Solutions business, resulting in the creation of a new #LifeSciences & #Diagnostics business. Learn more here.

[Revvity @RevvityInc]

Today PerkinElmer announced the completion of its divestiture of the Company’s Analytical & Enterprise Solutions business. More details on this transformation and the new, independent Life Sciences & Diagnostics business here: https://t.co/ozBatvR3t3

[Revvity IR @RevvityIR]

A tremendous amount of work by so many went into this! We are pleased to announce we have now completed the divestiture of our Analytical and Enterprise Service business to New Mountain Capital $PKI https://t.co/idFn5MtUhf

[Revvity IR @RevvityIR]

$PKI

[Revvity for Life Sciences @RevvityLifeSci]

We’re excited to announce the launch of our EnVision® Nexus™ multimode plate reader! See how it fast tracks #drugdiscovery research. Visit booth 1424. https://t.co/f4gPf4R0QS #SLAS2023

[Revvity IR @RevvityIR]

$PKI reported another quarter of better than expected results this morning for 4Q22 and provided our first strong outlook for our new standalone Life Science & Diagnostics business. Listen in to our investor call this morning at 8am ET here: https://t.co/zcBZ6pSiQY

[Revvity IR @RevvityIR]

It's pretty fun to get to work alongside all these smart people. Check out their thoughts on where various areas of science are headed in 2023 $PKI

[Revvity @RevvityInc]

Wondering what trends will shape #diagnostics and #lifesciences labs in 2023? Experts across our organization lend their insights in this blog post. https://t.co/ZRAPpoldJN